LACTOPY CoV | Designed to strengthen immune and promote respiratory health
What is a coronavirus?
Coronaviruses (CoV) are a large family of viruses that cause illness ranging from common cold to more severe diseases such as Middle East Respiratory Syndrome (MERS-CoV) and Severe Acute Respiratory Syndrome (SARS-CoV).
The most recently discovered coronavirus disease is COVID-19. According to World Health Organization (WHO), the disease spreads primarily through contact with an infected person when they cough or sneeze. It also spreads when a person touches a surface or object that has the virus on it, then touches their eyes, nose, or mouth.
Specially-blend formula with 4 types of probiotics
Lactobacillus sakei proBio65 – 10 Billion CFU per serving
Lactobacillus salivarius proBio37 – 10 Billion CFU per serving
Lactobacillus plantarum DR7 – 10 Billion CFU per serving
Lactobacillus plantarum proBio38 – 10 Billion CFU per serving
Each of the probiotics have specialized functionality and they work synergistically to enhance your respiratory and overall health.
L. salivarius proBio37 & L. plantarum proBio38 showed strong inhibition against transmissible gastroenteritis (TGE) coronavirus - which typically attack lungs and small intestines.
Potent antimicrobial activity against common respiratory pathogens (Streptococcus pneumoniae, Staphylococcus aureus & Klebsiella pneumoniae).
Clinical study showed that L. plantarum DR7 reduced the frequency of upper respiratory tract infections and duration of nasal symptoms in adults after 12 weeks.
In-depth research proved that L. sakei proBio65 & L. plantarum DR7 could modulate inflammatory markers (IFN-γ, TNF-α, IL-10 & IL-4), mediating immune response during respiratory infections.
Worldwide recognized patterns: